267 related articles for article (PubMed ID: 38198120)
1. Management of Paraneoplastic Syndromes in the Era of Immune Checkpoint Inhibitors.
Jean MJ; Samkoff L; Mohile N
Curr Treat Options Oncol; 2024 Jan; 25(1):42-65. PubMed ID: 38198120
[TBL] [Abstract][Full Text] [Related]
2. Updates in the Management of Paraneoplastic Syndrome.
Verma N; Jaffer MH; Kolli AS; Mokhtari S
Semin Neurol; 2024 Feb; 44(1):36-46. PubMed ID: 38183975
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
Blaes F
Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
[No Abstract] [Full Text] [Related]
4. Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New.
Gastaldi M; Scaranzin S; Pietro B; Lechiara A; Pesce G; Franciotta D; Lorusso L
Curr Oncol Rep; 2022 Oct; 24(10):1237-1249. PubMed ID: 35476177
[TBL] [Abstract][Full Text] [Related]
5. [Paraneoplastic syndromes: a review].
Berardi R; Grilli G; Romagnoli E; Saladino T; Freddari F; Tamburrano T; Galizia E; Carbonari G; Mariani C; Braconi C; Pierantoni C; Battelli N; Scartozzi M; Cascinu S
Clin Ter; 2005; 156(6):281-8. PubMed ID: 16463565
[TBL] [Abstract][Full Text] [Related]
6. New concepts in paraneoplastic neurological syndromes.
Honnorat J; Viaccoz A
Rev Neurol (Paris); 2011 Oct; 167(10):729-36. PubMed ID: 21890156
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic neurological syndromes--diagnosis and management.
Blaes F
Curr Pharm Des; 2012; 18(29):4518-25. PubMed ID: 22612756
[TBL] [Abstract][Full Text] [Related]
8. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force.
Vedeler CA; Antoine JC; Giometto B; Graus F; Grisold W; Hart IK; Honnorat J; Sillevis Smitt PA; Verschuuren JJ; Voltz R;
Eur J Neurol; 2006 Jul; 13(7):682-90. PubMed ID: 16834698
[TBL] [Abstract][Full Text] [Related]
9. [Paraneoplastic syndromes].
Krome S
Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S20-2. PubMed ID: 22438119
[No Abstract] [Full Text] [Related]
10. Paraneoplastic neurological syndromes: a single institution 10-year case series.
Chan AM; Baehring JM
J Neurooncol; 2019 Jan; 141(2):431-439. PubMed ID: 30607708
[TBL] [Abstract][Full Text] [Related]
11. S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).
Antiga E; Bech R; Maglie R; Genovese G; Borradori L; Bockle B; Caproni M; Caux F; Chandran NS; Corrà A; D'Amore F; Daneshpazhooh M; De D; Didona D; Dmochowski M; Drenovska K; Ehrchen J; Feliciani C; Goebeler M; Groves R; Günther C; Handa S; Hofmann SC; Horvath B; Ioannidis D; Jedlickova H; Kowalewski C; Kridin K; Joly P; Lim YL; Marinovic B; Maverakis E; Meijer J; Patsatsi A; Pincelli C; Prost C; Setterfield J; Sprecher E; Skiljevic D; Tasanen K; Uzun S; Van Beek N; Vassileva S; Vorobyev A; Vujic I; Wang G; Wang M; Wozniak K; Yayli S; Zambruno G; Hashimoto T; Schmidt E; Mascarò JM; Marzano AV
J Eur Acad Dermatol Venereol; 2023 Jun; 37(6):1118-1134. PubMed ID: 36965110
[TBL] [Abstract][Full Text] [Related]
12. Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes.
Farina A; Villagrán-García M; Vogrig A; Zekeridou A; Muñiz-Castrillo S; Velasco R; Guidon AC; Joubert B; Honnorat J
Lancet Neurol; 2024 Jan; 23(1):81-94. PubMed ID: 38101905
[TBL] [Abstract][Full Text] [Related]
13. CV2/CRMP5-antibody-related Paraneoplastic Neurologic Syndrome Associated with Gastrointestinal Stromal Tumor.
Fukushima H; Shibuya T; Awatsu T; Kurosawa T; Haga K; Murakami T; Serizawa N; Mori A; Hojo M; Yao T; Hattori N; Nagahara A
Intern Med; 2022 May; 61(10):1497-1501. PubMed ID: 34670904
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic Neurologic Disorders.
Gilligan M; McGuigan C; McKeon A
Curr Neurol Neurosci Rep; 2023 Mar; 23(3):67-82. PubMed ID: 36781586
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and management of paraneoplastic neurological syndromes].
Saji E; Kawachi I; Nishizawa M
Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
Braik T; Evans AT; Telfer M; McDunn S
Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment.
Bataller L; Dalmau J
Semin Neurol; 2003 Jun; 23(2):215-24. PubMed ID: 12894387
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic neurological syndromes.
Leypoldt F; Wandinger KP
Clin Exp Immunol; 2014 Mar; 175(3):336-48. PubMed ID: 23937626
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic syndromes associated with classic Hodgkin lymphoma, a systematic literature review.
El Fakih R; Bajuaifer YS; Shah AY; Sulaiman R; Almohamady R; ELGohary G; Alothaimeen HS; Aljurf M
Ann Hematol; 2024 Apr; 103(4):1131-1137. PubMed ID: 37428199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
